Primary Job Title Co-Founder & Chief Executive Officer Primary Organization Codagenix
Location New York, New York, United States Regions Greater New York Area, East Coast, Northeastern US Gender Male
LinkedIn View on LinkedIn
Dr. Coleman, together with Dr. Wimmer and Dr. Mueller, co-discovered the SAVE technology and co-founded Codagenix, Inc. His work focuses on rational gene design for vaccine construction. He has multiple high impact publications, is the primary investigator on externally funded research projects, and has project management skills in small business
and biotechnology. Dr. Coleman completed his MBA in finance while simultaneously co-founding Codagenix Inc., conducting research as a postdoc, and teaching/researching as an Assistant Professor. Dr. Coleman’s cross-functional skill set (strong science and finance) is capable of enhancing and expediting R & D milestones and will allow him to lead all facets of the R & D process. Dr. Coleman earned his BS from Tulane University, a PhD in Molecular Genetics and Microbiology from Stony Brook University, and a MBA from New York Institute of Technology.
